HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$33.79
Day range
$31.43 - $34.67
Year range
$5.35 - $40.22
Market cap
1.99B USD
Avg Volume
823.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.40M | -93.80% |
Operating expense | 62.84M | 73.27% |
Net income | -57.93M | -452.70% |
Net profit margin | -4.13K | -8,815.30% |
Earnings per share | -0.97 | -438.89% |
EBITDA | -61.03M | -364.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 284.67M | 31.25% |
Total assets | 418.43M | 54.09% |
Total liabilities | 65.98M | 55.12% |
Total equity | 352.46M | — |
Shares outstanding | 59.15M | — |
Price to book | 5.65 | — |
Return on assets | -39.45% | — |
Return on capital | -45.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -57.93M | -452.70% |
Cash from operations | -30.45M | -31.31% |
Cash from investing | -61.06M | -7,555.56% |
Cash from financing | 92.34M | 16,157.22% |
Net change in cash | 826.00K | 103.79% |
Free cash flow | -8.63M | 28.57% |
About
Founded
2014
Headquarters
Website
Employees
170
